MARIPAT ALGER COTTONE: Open Payments
NPI 1467460626 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,832 in 83 payments from 15 companies in 2025. Trend: 2023 $582 · 2024 $869 · 2025 $1,832
Food & beverage: $1,720Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $402 |
| Teva Pharmaceuticals USA, Inc. | 5 | $274 |
| ABBVIE INC. | 22 | $260 |
| Neurocrine BioSciences, Inc. | 5 | $194 |
| Alpha Cognition USA, Inc. | 2 | $174 |
| Alkermes, Inc. | 7 | $134 |
| Vanda Pharmaceuticals Inc. | 5 | $85 |
| Lundbeck LLC | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: REXULTI, VRAYLAR, INGREZZA, Zunveyl, AUSTEDO XR, ARISTADA, FANAPT, COBENFY.
Industry payments across NJ — which companies pay providers there.
